Current Assets | 2.74 B |
Cash & Short-Term Investments | 331 M |
Receivables | 839 M |
Other Current Assets | 1.57 B |
Non-Current Assets | 10.7 B |
Long-Term Investments | 133 M |
PP&E | 1.39 B |
Other Non-Current Assets | 9.18 B |
Current Liabilities | 1.58 B |
Accounts Payable | 522 M |
Short-Term Debt | 30 M |
Other Current Liabilities | 1.03 B |
Non-Current Liabilities | 4.94 B |
Long-Term Debt | 4.62 B |
Other Non-Current Liabilities | 324 M |
Revenue | 4.15 B |
Cost Of Revenue | 1.64 B |
Gross Profit | 2.5 B |
Operating Expenses | 2.37 B |
Operating Income | 130 M |
Other Expenses | 378 M |
Net Income | -248 M |
Net Income | -248 M |
Depreciation & Amortization | 382 M |
Capital Expenditures | -181 M |
Stock-Based Compensation | 74 M |
Change in Working Capital | -287 M |
Others | -75 M |
Free Cash Flow | -198 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
5 months ago
Aug 05, 2024
|
Bought
505 K USD
|
SAUNDERS BRENT L
CEO and Chairman of the Board
|
+ 32250
|
15.661 USD |
2 years ago
Jun 01, 2022
|
Sell 77.6 M
USD
|
Bausch Health Companies Inc.
director:
|
- 4550357
|
17.055 USD |
2 years ago
May 10, 2022
|
Sell 597 M
USD
|
Bausch Health Companies Inc.
director:
|
- 35000000
|
17.055 USD |